Cargando…

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis

BACKGROUND: The clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis have not been evaluated yet. AIM: To evaluate the clinical efficacy and safety of vaccination against COVID-19 in patients with cirrhosis. METHODS: This was a retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivashkin, Vladimir, Ismailova, Albina, Dmitrieva, Ksenia, Maslennikov, Roman, Zharkova, Maria, Aliev, Salekh, Bakhitov, Vyacheslav, Marcinkevich, Vadim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376781/ https://www.ncbi.nlm.nih.gov/pubmed/36158923 http://dx.doi.org/10.4254/wjh.v14.i7.1470

Ejemplares similares

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites
por: Alvarado-Tapias, Edilmar, et al.
Publicado: (2018)

Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk
por: Thakrar, Sonali V, et al.
Publicado: (2017)

Assessment of resting energy expenditure in patients with cirrhosis
por: Ferreira, Shaiane, et al.
Publicado: (2022)

Evaluation of the nutritional status of patients with liver cirrhosis
por: Janota, Barbara, et al.
Publicado: (2023)

Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
por: Cai, Sheng-Wei, et al.
Publicado: (2022)

Hospital resource intensity and cirrhosis mortality in United States
por: Mathur, Amit K, et al.
Publicado: (2017)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Efficacy and safety of stellate ganglion block in chronic ulcerative colitis
por: Zhao, Hong-Ying, et al.
Publicado: (2017)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study
por: Rojas-Loureiro, Gabriela, et al.
Publicado: (2017)

Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients
por: Kraja, Bledar, et al.
Publicado: (2017)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
por: Korbut, Anton I, et al.
Publicado: (2019)

Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity
por: Tsiompanidis, Elias, et al.
Publicado: (2018)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
por: Abadía, Marta, et al.
Publicado: (2019)

Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis
por: Gupta, Tarana, et al.
Publicado: (2022)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Outcomes of gout in patients with cirrhosis: A national inpatient sample-based study
por: Khrais, Ayham, et al.
Publicado: (2023)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Malnutrition and non-compliance to nutritional recommendations in patients with cirrhosis are associated with a lower survival
por: Crisan, Dana, et al.
Publicado: (2020)

Difference and clinical value of metabolites in plasma and feces of patients with alcohol-related liver cirrhosis
por: Xu, Yi-Fan, et al.
Publicado: (2023)

Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients
por: Noiphithak, Raywat, et al.
Publicado: (2023)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
por: Arya, Rahul, et al.
Publicado: (2023)

Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer
por: Liang, Jian-Jing, et al.
Publicado: (2023)

Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients
por: Riedel, Agnete Nordheim, et al.
Publicado: (2018)

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
por: Brzdęk, Michał, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c1fptqc853f3cols5s0aahnjbv